Humphrey Pullon

468 total citations
11 papers, 114 citations indexed

About

Humphrey Pullon is a scholar working on Genetics, Immunology and Hematology. According to data from OpenAlex, Humphrey Pullon has authored 11 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 4 papers in Hematology. Recurrent topics in Humphrey Pullon's work include Complement system in diseases (4 papers), Acute Myeloid Leukemia Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Humphrey Pullon is often cited by papers focused on Complement system in diseases (4 papers), Acute Myeloid Leukemia Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Humphrey Pullon collaborates with scholars based in New Zealand, Hong Kong and United Kingdom. Humphrey Pullon's co-authors include A. J. Bellingham, Pascal Deschatelets, Lisa Tan, Cedric Francois, F Grossi, Pimjai Niparuck, Raymond Wong, Tontanai Numbenjapon, Surapol Issaragrisil and Jameela Sathar and has published in prestigious journals such as Blood, Bone and British Journal of Haematology.

In The Last Decade

Humphrey Pullon

9 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Humphrey Pullon New Zealand 6 60 49 32 28 25 11 114
Elizabeth Chalmers United Kingdom 3 81 1.4× 186 3.8× 31 1.0× 64 2.3× 44 1.8× 3 248
Tania Robe-Rybkine France 4 88 1.5× 63 1.3× 51 1.6× 57 2.0× 60 2.4× 5 189
Michael Gattens United Kingdom 7 56 0.9× 61 1.2× 10 0.3× 34 1.2× 32 1.3× 9 121
Janine Collins United Kingdom 6 17 0.3× 97 2.0× 22 0.7× 37 1.3× 7 0.3× 13 131
Agathe Debliquis France 6 39 0.7× 23 0.5× 17 0.5× 35 1.3× 14 0.6× 17 92
Francisco Bracho United States 6 33 0.6× 33 0.7× 11 0.3× 19 0.7× 4 0.2× 12 96
Nobuo Sezaki Japan 7 26 0.4× 48 1.0× 23 0.7× 18 0.6× 2 0.1× 13 104
Mark Kačar United Kingdom 7 71 1.2× 50 1.0× 64 2.0× 10 0.4× 9 0.4× 14 142
Heike Martin Germany 4 20 0.3× 11 0.2× 29 0.9× 12 0.4× 7 0.3× 5 68
Sadaf Pakdaman France 8 25 0.4× 168 3.4× 23 0.7× 149 5.3× 9 0.4× 14 222

Countries citing papers authored by Humphrey Pullon

Since Specialization
Citations

This map shows the geographic impact of Humphrey Pullon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humphrey Pullon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humphrey Pullon more than expected).

Fields of papers citing papers by Humphrey Pullon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humphrey Pullon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humphrey Pullon. The network helps show where Humphrey Pullon may publish in the future.

Co-authorship network of co-authors of Humphrey Pullon

This figure shows the co-authorship network connecting the top 25 collaborators of Humphrey Pullon. A scholar is included among the top collaborators of Humphrey Pullon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Humphrey Pullon. Humphrey Pullon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
McQuilten, Zoe, Robert Weinkove, Lê Thị Phương Thảo, et al.. (2024). Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy. Blood Advances. 8(7). 1787–1795. 5 indexed citations
2.
3.
Wong, Raymond, Humphrey Pullon, Andrija Bogdanović, et al.. (2022). Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 101(9). 1971–1986. 33 indexed citations
4.
Spencer, Andrew, Peter Browett, Frank Alvaro, et al.. (2020). High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission. Bone Marrow Transplantation. 55(11). 2207–2210.
5.
Wong, Raymond, Humphrey Pullon, Jameela Sathar, et al.. (2020). C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials. Blood. 136(Supplement 1). 3–4. 5 indexed citations
6.
Wong, Raymond, Humphrey Pullon, Pascal Deschatelets, et al.. (2018). Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). Blood. 132(Supplement 1). 2314–2314. 22 indexed citations
7.
Mehdi, Delphine El, F Grossi, Pascal Deschatelets, et al.. (2017). APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. Molecular Immunology. 89. 115–115. 6 indexed citations
8.
Pullon, Humphrey, et al.. (2016). Antimicrobial resistance in New Zealand: the evidence and a call for action.. PubMed. 129(1444). 103–110.
10.
Pullon, Humphrey, et al.. (1991). The osteodystrophy of congenital erythropoietic porphyria. Bone. 12(2). 89–92. 13 indexed citations
11.
Brito‐Babapulle, F., Humphrey Pullon, D. Mark Layton, et al.. (1990). Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype. British Journal of Haematology. 76(2). 210–214. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026